N. A. A. H. Alshimary and T.-A. R. Tweij, “Praliciguat alleviates ferroptosis and inflammation in renal ischemia/reperfusion injury by targeting the AMPK/ACC/PUFA pathway”, Babcock Univ. Med. J., vol. 8, no. 2, pp. 198–207, Dec. 2025.